Financials

  • Market Capitalization 7 M
  • Employee 10
  • Founded 2003
  • CEO N/A
  • Website www.ensysce.com
  • Headquarter Delaware, United States
  • FIGI BBG00JFF4174
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.12
Rapporto prezzo/fatturato
0.26

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4859
CURX
Curanex Pharmaceuticals Inc - Common Stock
4.64 USD-1.49%+2109.52%+2220.00%+22.11%7.28 M USD
4862
ALZN
Alzamend Neuro, Inc. - Common Stock
1.45 USD-7.05%-6.45%+7.41%-40.82%6.95 M USD
4873
IMRN
Immuron Limited - American Depositary Shares
1.14 USD0.00%+5.56%+1.79%-36.67%6.67 M USD
4875
LIMN
Liminatus Pharma, Inc. - Class A Common Stock
4.62 USD-10.29%+3200.00%+4100.00%+40.85%6.21 M USD

Notizie